Author:
Arguedas Adriano,Cespedes Jaime,Botet Francesc Aseni,Blumer Jeffrey,Yogev Ram,Gesser Richard,Wang Jean,West Joseph,Snyder Theresa,Wimmer Wendy
Subject
Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine
Reference15 articles.
1. In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intraabdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART);Paterson;J Antimicrob Chemother,2005
2. European Agency for the Evaluation of Medicinal Products. Committee for Proprietary Medicinal Products (CPMP). Note for guidance on evaluation of medicinal products indicated for treatment of bacterial infections. CPMP/EWP/558/95 rev 1, 22 April 2004. http://www.emea.europa.eu/pdfs/human/ewp/055895en.pdf [accessed 17 March 2008].
3. In vitro activities of ertapenem (MK-0826) against clinical bacterial isolates from 11 North American medical centers;Fuchs;Antimicrob Agents Chemother,2001
4. In vitro activity of ertapenem (MK-0826) against multi-drug resistant Streptococcus pneumoniae compared with 13 other antimicrobials;Hilliard;Int J Antimicrob Agents,2002
5. Antibacterial susceptibility of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli;Bishara;Isr Med Assoc J,2005
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献